about
Analysis of structure-function relationships in the colibactin-maturating enzyme ClbPHigh incidence of unrecognized visceral/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data setsPituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and miceNecroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.Chromosome-mediated OXA-48 carbapenemase in highly virulent Escherichia coli.Noncovalent complexes of an inactive mutant of CTX-M-9 with the substrate piperacillin and the corresponding product.Targeting colorectal cancer-associated bacteria: A new area of research for personalized treatments.Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria.Antibiotic Activity of Escherichia coli against Multiresistant Staphylococcus aureusFTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.The Role of Autophagy in the Degradation of Misfolded HLA-B27 Heavy Chains.Association of NPC1 variant p.P237S with a pathogenic splice variant in two Niemann-Pick disease type C1 patients.Altered cerebrospinal fluid proteins in Smith-Lemli-Opitz syndrome patients.Necroptosis inhibition as a therapy for Niemann-Pick disease, type C1: Inhibition of RIP kinases and combination therapy with 2-hydroxypropyl-β-cyclodextrinMicroglia activation in Niemann-Pick disease, type C1 is amendable to therapeutic interventionDifferential Proteomics Reveals miR-155 as a Novel Indicator of Liver and Spleen Pathology in the Symptomatic Niemann-Pick Disease, Type C1 Mouse ModelGastrointestinal Tract Pathology in a BALB/c Niemann-Pick Disease Type C1 Null Mouse ModelEvaluation of age of death in Niemann-Pick disease, type C: Utility of disease support group websites to understand natural history
P50
Q27682692-CCA30942-840A-44F5-BFCA-67D1D632AE46Q35575793-E7A7B9A1-B681-4940-88AC-B275801AE49CQ35578261-59F357C0-4205-4B87-9E85-2D9A5C1461A2Q36774925-5CC0E865-FC59-4AEE-BE8B-88AAB349D9A0Q39459908-8E5346B7-9D80-4065-BA06-124CC76E0E9EQ39659490-6DCB8004-4F61-4B44-A329-CEE6960BCA7EQ40743780-DF468219-FD28-4416-AA99-31A613220DACQ41583397-8492D99F-4DC8-4178-8BB2-BCB43FF63B30Q42380917-846AC87F-215D-463A-9443-32424D1F3175Q42803814-EBA681AD-51DE-459E-82D1-620865B8F829Q49998468-35128A05-3E9E-4F9D-9525-2C2F31D6A85AQ52780483-EC089AF1-FF9C-4818-8327-7524DD15D7AFQ54858134-969F1315-87DB-44A4-9FBE-12CA5E641A26Q58594062-BA4890CB-C516-4D4E-8D77-204C15E0161CQ59291044-D72FD438-6CAE-40B1-B741-C1512DDC8595Q64104342-77EF0084-4B49-4E58-878F-0A8D5D1CC7E1Q89935084-554C0B4C-3546-4ADE-B045-E1DC65C2CEC3Q92234435-D09CC992-3225-495C-ABB8-7018629A0A01
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-9407-7540
@en
name
Antony Cougnoux
@ast
Antony Cougnoux
@en
Antony Cougnoux
@es
Antony Cougnoux
@nl
type
label
Antony Cougnoux
@ast
Antony Cougnoux
@en
Antony Cougnoux
@es
Antony Cougnoux
@nl
prefLabel
Antony Cougnoux
@ast
Antony Cougnoux
@en
Antony Cougnoux
@es
Antony Cougnoux
@nl
P106
P108
P21
P31
P496
0000-0001-9407-7540